Dolby Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Dolby Laboratories has a total shareholder equity of $2.5B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $3.1B and $623.0M respectively. Dolby Laboratories's EBIT is $264.7M making its interest coverage ratio -7.8. It has cash and short-term investments of $482.0M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -7.8x |
| Cash | US$482.05m |
| Equity | US$2.49b |
| Total liabilities | US$623.04m |
| Total assets | US$3.11b |
Recent financial health updates
No updates
Recent updates
Dolby Laboratories (NYSE:DLB) Hasn't Managed To Accelerate Its Returns
Oct 28
Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?
Sep 22Dolby Laboratories: Need To See Improvements In Sales Before Committing Capital
Aug 22Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Matching Investor Opinion
Aug 13We Like These Underlying Return On Capital Trends At Dolby Laboratories (NYSE:DLB)
Jul 26Dolby Laboratories: A Sound Player, Trading At A Too-Rich Valuation
Jun 10Should You Think About Buying Dolby Laboratories, Inc. (NYSE:DLB) Now?
Jun 07Dolby Laboratories Remains A Hold
May 14Dolby Laboratories, Inc. (NYSE:DLB) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 05Dolby Laboratories, Inc.'s (NYSE:DLB) Earnings Haven't Escaped The Attention Of Investors
May 02Investors Will Want Dolby Laboratories' (NYSE:DLB) Growth In ROCE To Persist
Apr 16Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 26% Below Their Intrinsic Value Estimate
Mar 17Dolby Laboratories Sees Flat Revenue Ahead (Downgrade)
Mar 01Dolby Laboratories' (NYSE:DLB) Earnings Offer More Than Meets The Eye
Feb 09What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
Jan 31With Dolby Laboratories, Inc. (NYSE:DLB) It Looks Like You'll Get What You Pay For
Jan 15The Return Trends At Dolby Laboratories (NYSE:DLB) Look Promising
Dec 28Dolby Laboratories: On A Positive Hold As Shareholder Rewards Continue
Dec 06A Look At The Fair Value Of Dolby Laboratories, Inc. (NYSE:DLB)
Nov 18At US$81.66, Is Dolby Laboratories, Inc. (NYSE:DLB) Worth Looking At Closely?
Oct 11Dolby Laboratories: High P/E Is Not Justified, A Hold For Now
Sep 13The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing
Aug 03What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
Jul 12Dolby Laboratories Sees Return To Growth Ahead
Jun 22Returns On Capital At Dolby Laboratories (NYSE:DLB) Paint A Concerning Picture
May 04A Look At The Intrinsic Value Of Dolby Laboratories, Inc. (NYSE:DLB)
Apr 14Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?
Mar 29Dolby Laboratories goes ex-dividend on Monday
Feb 10Financial Position Analysis
Short Term Liabilities: DLB's short term assets ($1.2B) exceed its short term liabilities ($417.8M).
Long Term Liabilities: DLB's short term assets ($1.2B) exceed its long term liabilities ($205.2M).
Debt to Equity History and Analysis
Debt Level: DLB is debt free.
Reducing Debt: DLB has not had any debt for past 5 years.
Debt Coverage: DLB has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: DLB has no debt, therefore coverage of interest payments is not a concern.